Search
for

    Sort by

    Research 151–180 of 176

    1. The interaction between finasteride and corticosterone levels: implications for depression-, and anxiety-like behavior and hippocampal synaptic plasticity in male rats Psychopharmacology · 2025
    2. Managing Common Dermatologic Needs in Transgender and Gender-Diverse Adolescents Current Pediatrics Reports · 2025
    3. Differential association between cumulative dose of 5α-reductase inhibitors and mortality Scientific Reports · 2025
    4. Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review Journal of Education Health and Sport · 2025
    5. Finasteride Use: Evaluation of Depression and Suicide Risk Journal of Cosmetic Dermatology · 2025
    6. Post-finasteride syndrome - a true clinical entity? International Journal of Impotence Research · 2025
    7. Análisis de las Interacciones Químicas-Cuánticas in Silico de la Finasterida y los Neurotransmisores y su Papel en la Psicopatología Ciencia Latina Revista Científica Multidisciplinar · 2025
    8. Male androgenetic alopecia Anais Brasileiros de Dermatologia · 2025
    9. Efficacy, safety, and adverse effects of finasteride and dutasteride in treating benign prostatic hyperplasia: A retrospective cohort study Zanco Journal of Medical Sciences · 2024
    10. The Nutrient–Skin Connection: Diagnosing Eating Disorders Through Dermatologic Signs Nutrients · 2024
    11. Post‐finasteride syndrome: real or myth? Trends in Urology & Men s Health · 2024
    12. Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations Cosmetics · 2024
    13. The Relationship Between Mental Health and Drugs used in Dermatology Journal of Education, Health and Sport · 2024
    14. Evaluating the psychosocial impact of gender‐affirming dermatology treatments: A systematic review JEADV clinical practice · 2024
    15. Comment on Current Investigations into the Postfinasteride Syndrome International Journal of Trichology · 2024
    16. Lifestyle interventions in dermatology Cosmoderma · 2023
    17. POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE Frontiers in Neuroendocrinology · 2023
    18. Patient prioritisation of impact items to develop the patient‐reported impact of dermatological diseases (PRIDD) measure: European Delphi data Journal of the European Academy of Dermatology and Venereology · 2023
    19. The Impact of Gender Affirming Hormone Therapy on Physical Performance The Journal of Clinical Endocrinology and Metabolism · 2023
    20. Cold atmospheric microwave plasma (CAMP) stimulates dermal papilla cell proliferation by inducing β-catenin signaling Scientific Reports · 2023
    21. Effect of Skin Type on Efficacy of Laser Treatment for Androgenetic Alopecia: A Review of the Literature Skin appendage disorders · 2023
    22. Kaleidoscope The British Journal of Psychiatry · 2021
    23. BPH Medications May Increase Risk of Self-Harm, Depression Psychiatric news · 2017
    24. US Food and Drug Administration Warning Regarding Finasteride and Suicidal Ideation: What Should Urologists Know? European urology open science · 2023
    25. Pediatric androgenetic alopecia: an updated review Journal der Deutschen Dermatologischen Gesellschaft · 2023
    26. Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients Translational Andrology and Urology · 2022
    27. Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis European Journal of Clinical Pharmacology · 2025 · 1 citations
    28. Association of Hair Loss With Suicidality and Psychological Adverse Events vs Finasteride Use—Reply JAMA Dermatology · 2021 · 1 citations
    29. Suicidality and Psychological Adverse Events in Patients Treated with Finasteride Skin appendage disorders · 2021 · 1 citations
    30. (719) Signal Detection of Depression and Suicidality With the 5-Alpha Reductase Inhibitors: Evidence from the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) Database The Journal of Sexual Medicine · 2026